PLA2G2A and infection: These disparate platforms have intriguing uses: AMP-functionalized protein polymers are under development for infection-resistant wound dressings; venom PLA2 and proteomes show potential in the prevention of biofilm; and venom-derived AMP-based controlled-release systems are being explored to modulate infection in medical devices [165].